KRAS and Cirrhosis: On the other hand, Hézode et al. [32] reported that 2 patients met severe side effects such as pulmonary arterial hypertension and acute-on-chronic liver failure which may be attributed to the presence of cirrhosis and NS5A and/or NS3 protease resistance-associated [22, 33, 34].